These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12418292)

  • 1. [Interferences in immunoassay].
    Sztefko K
    Przegl Lek; 2002; 59(6):477-80. PubMed ID: 12418292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False-positive immunoassay results: a multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries.
    Marks V
    Clin Chem; 2002 Nov; 48(11):2008-16. PubMed ID: 12406987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference by heterophilic antibodies in immunoassays: wrong increase of myoglobin values.
    Bonetti A; Monica C; Bonaguri C; Gnocchi C; Russo A; Battistelli L; Musiari L; Pastori P; Novarini A
    Acta Biomed; 2008 Aug; 79(2):140-3. PubMed ID: 18788511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera.
    Bolstad N; Warren DJ; Bjerner J; Kravdal G; Schwettmann L; Olsen KH; Rustad P; Nustad K
    Clin Chem Lab Med; 2011 Sep; 49(12):2001-6. PubMed ID: 21899496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences.
    Piketty ML; Polak M; Flechtner I; Gonzales-Briceño L; Souberbielle JC
    Clin Chem Lab Med; 2017 May; 55(6):780-788. PubMed ID: 27732554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical error and interference in immunoassay: minimizing risk.
    Sturgeon CM; Viljoen A
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):418-32. PubMed ID: 21750113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diagnostic conundrum: heterophilic antibody interference in an adrenocorticotropic hormone immunoassay not detectable using a proprietary heterophile blocking reagent.
    Grasko J; Willliams R; Beilin J; Glendenning P; Fermoyle S; Vasikaran S
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):433-7. PubMed ID: 23873871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference in the autoDELFIA(R) hAFP immunoassay and effect on second-trimester Down's syndrome screening.
    Mannings L; Trow S; Newman J; Nix B; Evans C
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):438-40. PubMed ID: 21795408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Black Swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods.
    Clerico A; Belloni L; Carrozza C; Correale M; Dittadi R; Dotti C; Fortunato A; Vignati G; Zucchelli GC; Migliardi M;
    Clin Chem Lab Med; 2018 Feb; 56(3):397-402. PubMed ID: 29220884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSH-assay interference: still with us.
    Verdickt L; Maiter D; Depraetere L; Gruson D
    Clin Lab; 2012; 58(11-12):1305-7. PubMed ID: 23289203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality specifications for biochemical markers of myocardial injury.
    Zaninotto M; Mion M; Altinier S; Forni M; Plebani M
    Clin Chim Acta; 2004 Aug; 346(1):65-72. PubMed ID: 15234637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total beta-hCG test.
    Cole LA; Khanlian SA
    Clin Biochem; 2004 May; 37(5):344-9. PubMed ID: 15087248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What to do in the event of a suspicion of analytical interference during an immunoassay?].
    Lauro C; Corcuff JB; Brossaud J; Georges A
    Ann Biol Clin (Paris); 2020 Feb; 78(1):70-73. PubMed ID: 32108582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical repercussions of analytical interferences due to aldosterone antagonists in digoxin immunoassays: an assessment.
    Cobo A; Martín-Suarez A; Calvo MV; Domínguez-Gil A; de Gatta MM
    Ther Drug Monit; 2010 Apr; 32(2):169-76. PubMed ID: 20216123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not Available].
    Tjernberg I; Gustafsson I
    Lakartidningen; 2018 Jan; 115():. PubMed ID: 29360135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Chinese medicines Chan Su and Lu-Shen-Wan on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.
    Reyes MA; Actor JK; Risin SA; Dasgupta A
    Ther Drug Monit; 2008 Feb; 30(1):95-9. PubMed ID: 18223469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotin: an emerging analytical interference.
    Piketty ML; Souberbielle JC
    Ann Biol Clin (Paris); 2017 Aug; 75(4):366-368. PubMed ID: 28751281
    [No Abstract]   [Full Text] [Related]  

  • 19. Rebuttal to "Easy fix for clinical laboratories for the false positive defect with Abbott AxSYM Total BhCG test" by Dr. Laurence Cole, Clin Biochem, 37(5), 344-349 (2004).
    Koziarz JJ
    Clin Biochem; 2004 Jun; 37(6):500; author reply 501. PubMed ID: 15183299
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoassay interference caused by heterophilic antibodies interacting with biotin.
    Vos MJ; Rondeel JMM; Mijnhout GS; Endert E
    Clin Chem Lab Med; 2017 May; 55(6):e122-e126. PubMed ID: 27754962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.